Compounds and compositions as c-kit and PDGFR kinase inhibitors
US8338417B2 · kind B2 · utility
64Cited by
2References
8Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | May 2, 2008 |
| Grant date | Dec 25, 2012 |
| Priority date | — |
| Expiry date | Mar 10, 2029 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D417/14
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention provides a novel class of compounds, pharmaceutical compositions comprising such compounds and methods of using such compounds to treat or prevent diseases or disorders associated with abnormal or deregulated kinase activity, particularly diseases or disorders that involve abnormal activation of c-kit, PDGFR and PDGFR kinases.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.